Phospholamban antibody (Thr17)
Quick Overview for Phospholamban antibody (Thr17) (ABIN954126)
Target
See all Phospholamban (PLN) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- Thr17
-
Specificity
- This antibody recognizes Human Phospholamban (Thr17).
-
Purification
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide selected from the Thr17 region of Human Phospholamban Genename: PLN
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- Phospholamban (PLN)
-
Alternative Name
- Phospholamban
-
Background
- PLB is a 52 amino acid phosphoprotein which regulates the calcium pump of cardiac sarcoplasmic reticulum (SR). PLB is an oligomer of five identical subunits each having a cytoplasmic and transmembrane domain. The cytoplasmic domain (residues 1 to 25) contains the phosphorylation sites and is highly basic and readily cleaved by proteases, whereas the transmembrane domain (residues 25 to 52) is mostly hydrophobic, protease resistant and stabilizes the pentamer.Synonyms: Cardiac phospholamban, PLB, PLN
-
Molecular Weight
- 6109 Da
-
Gene ID
- 5350
-
NCBI Accession
- NP_002658
-
Pathways
- Negative Regulation of Transporter Activity
Target
-